Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.

With > 1.5 years of follow-up, intraoperative brachytherapy with commercially available Cs131 implants was associated with favorable local control and toxicity profiles. Weak correlation between preoperative tumor geometry and implanted tiles highlights a need to optimize planning criteria.